DK271488A - Monoklonalt, paratopisk molekyle, som binder immunologisk til gangliosid gd2, og dets anvendelse - Google Patents
Monoklonalt, paratopisk molekyle, som binder immunologisk til gangliosid gd2, og dets anvendelseInfo
- Publication number
- DK271488A DK271488A DK271488A DK271488A DK271488A DK 271488 A DK271488 A DK 271488A DK 271488 A DK271488 A DK 271488A DK 271488 A DK271488 A DK 271488A DK 271488 A DK271488 A DK 271488A
- Authority
- DK
- Denmark
- Prior art keywords
- ganglioside
- monoclonal
- molecule binding
- paratopic molecule
- immunological
- Prior art date
Links
- CXQCLLQQYTUUKJ-ALWAHNIESA-N beta-D-GalpNAc-(1->4)-[alpha-Neup5Ac-(2->8)-alpha-Neup5Ac-(2->3)]-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer(d18:1/18:0) Chemical compound O[C@@H]1[C@@H](O)[C@H](OC[C@H](NC(=O)CCCCCCCCCCCCCCCCC)[C@H](O)\C=C\CCCCCCCCCCCCC)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@@H](CO)O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)C(O)=O)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](CO)O1 CXQCLLQQYTUUKJ-ALWAHNIESA-N 0.000 title 1
- 230000001900 immune effect Effects 0.000 title 1
- 230000009149 molecular binding Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90922586A | 1986-09-19 | 1986-09-19 | |
PCT/US1987/002419 WO1988002117A1 (en) | 1986-09-19 | 1987-09-18 | Monoclonal paratopic molecule directed to human ganglioside gd2 |
Publications (2)
Publication Number | Publication Date |
---|---|
DK271488A true DK271488A (da) | 1988-05-18 |
DK271488D0 DK271488D0 (da) | 1988-05-18 |
Family
ID=25426845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK271488A DK271488D0 (da) | 1986-09-19 | 1988-05-18 | Monoklonalt, paratopisk molekyle, som binder immunologisk til gangliosid gd2, og dets anvendelse |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0282581A4 (da) |
AU (1) | AU617652B2 (da) |
DK (1) | DK271488D0 (da) |
FI (1) | FI882340L (da) |
WO (1) | WO1988002117A1 (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4844893A (en) * | 1986-10-07 | 1989-07-04 | Scripps Clinic And Research Foundation | EX vivo effector cell activation for target cell killing |
DE3909799A1 (de) | 1989-03-24 | 1990-09-27 | Behringwerke Ag | Monoklonale antikoerper (mak) gegen tumorassoziierte antigene, ihre herstellung und verwendung |
DE4107154A1 (de) * | 1990-10-11 | 1992-04-16 | Boehringer Mannheim Gmbh | Monoklonale antikoerper gegen melanom |
US6667156B2 (en) * | 1995-12-27 | 2003-12-23 | Uab Research Foundation | Diagnosis and treatment of neuroectodermal tumors |
WO1997040140A1 (en) * | 1996-04-22 | 1997-10-30 | The Wistar Institute Of Anatomy And Biology | Gd2 anti-idiotypic antibodies and uses thereof |
JP2011520914A (ja) | 2008-05-15 | 2011-07-21 | トランスモレキュラー, インコーポレイテッド | 転移腫瘍の処置 |
JP5858932B2 (ja) | 2010-02-04 | 2016-02-10 | モルフォテック, インコーポレイテッド | クロロトキシンポリペプチドおよびコンジュゲートならびにその使用 |
EP2569330B1 (en) | 2010-05-11 | 2016-09-28 | Fred Hutchinson Cancer Research Center | Chlorotoxin variants, conjugates, and methods for their use |
EP2928913A1 (en) | 2012-12-10 | 2015-10-14 | Fred Hutchinson Cancer Research Center | Lipocalin fusion partners |
US11559580B1 (en) | 2013-09-17 | 2023-01-24 | Blaze Bioscience, Inc. | Tissue-homing peptide conjugates and methods of use thereof |
US12048732B2 (en) | 2016-04-15 | 2024-07-30 | Blaze Bioscience, Inc. | Methods of treating breast cancer |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4675287A (en) * | 1984-07-26 | 1987-06-23 | Scripps Clinic And Research Foundation | Monoclonal antibody directed to human ganglioside GD2 |
-
1987
- 1987-09-18 AU AU80711/87A patent/AU617652B2/en not_active Ceased
- 1987-09-18 WO PCT/US1987/002419 patent/WO1988002117A1/en not_active Application Discontinuation
- 1987-09-18 EP EP19870906712 patent/EP0282581A4/en not_active Ceased
-
1988
- 1988-05-18 DK DK271488A patent/DK271488D0/da not_active Application Discontinuation
- 1988-05-18 FI FI882340A patent/FI882340L/fi not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0282581A4 (en) | 1988-11-02 |
AU8071187A (en) | 1988-04-07 |
EP0282581A1 (en) | 1988-09-21 |
WO1988002117A1 (en) | 1988-03-24 |
FI882340A0 (fi) | 1988-05-18 |
FI882340L (fi) | 1988-05-18 |
AU617652B2 (en) | 1991-12-05 |
DK271488D0 (da) | 1988-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK486087A (da) | Receptormolekyle for antistof og dets anvendelse | |
NO872729D0 (no) | Cefalosporinhydrat og fremgangsmaate for dets fremstilling. | |
DK488885D0 (da) | 9-amino-1,2,3,4-tetrahydroacridin-1-ol og beslaegtede forbindelser, enfremgangsmaade til deres fremstilling og deres anvendelse som laegemidler | |
DK138786A (da) | Monoklont antistof rettet mod humant gangliosid gd2 | |
DK522383D0 (da) | Aluminium-n-phosphonomethylglycin og dets anvendelse som herbicid | |
DK299783D0 (da) | Monoklont antistof, dets fremstilling og anvendelse | |
DK271488A (da) | Monoklonalt, paratopisk molekyle, som binder immunologisk til gangliosid gd2, og dets anvendelse | |
NO169068C (no) | Bis-(2-etylamino-4-dietylamino-s-triazin-6-yl)-tetrasulfid, fremgangsmaate til fremstilling og dets anvendelse | |
DK84588D0 (da) | Phenylguanidin- og tetrahydropyrimidinholdigt anthelmikum, dets fremstilling og anvendelse | |
NO176924C (no) | Antistoffpreparat til ikke-terapeutisk anvendelse | |
DK554283A (da) | Desinficerende praeparat til topisk anvendelse | |
ATE136903T1 (de) | Impfstoff, der zecken-antigene enthält | |
DK525687A (da) | Enzymholdigt praeparat, dets fremstilling og anvendelse | |
DK50387A (da) | Rekombinant-humant interleukin-2-praeparat og frem-gangsmaade til dets fremstilling | |
DE3780256D1 (de) | Anti-pci-monoklonaler antikoerper. | |
DE3460284D1 (de) | Method to prepare 4,4'-bis-benz-ox(thi, -imid)-azol-2-yl stilbenes | |
IT8548762A0 (it) | Linfochina, suo anticorpo specifico monoclonale e relativo procedimentodi produzione | |
DK270386D0 (da) | Monoklonalt antistof til humant protein c, dets fremstilling og anvendelse | |
DK513784A (da) | Iodacetamider, deres fremstilling og anvendelse til skadedyrsbekaempelse | |
DK226085D0 (da) | 7-amino-3-(3-formamidopyridinium)-methyl-3-cephem-4-carboxylat, dets fremstilling og anvendelse til antibiotikasyntese | |
NO871219D0 (no) | Elastisk bind for engangsbruk. | |
DE3689183D1 (de) | Monoklonaler Antiasialo-GM1-Antikörper. | |
DK107987A (da) | Efterloeber til plov | |
DK673789D0 (da) | Monoklonalt antistof, som specifikt binder til kc-48-antigenet i neutrophiler og eosinophiler, samt hybridomocellelinie, som producerer antistoffet | |
NO162181C (no) | Binding for langrennsski. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |